Mode
Text Size
Log in / Sign up
Phase 4 Completed N=425 Randomized Single-blind Treatment

A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment Versus Golytely for Bowel Cleansing Prior to Colonoscopy

Colonoscopy
Source: ClinicalTrials.gov NCT00953017 ↗
Enrolled (actual)
425
Serious AEs
0.0%
Results posted
Nov 2012
Primary outcomePrimary: The Cleanliness of the Prep as Measured by the Ottawa Scale — 6.3; 6.8; 6.9; 5.1 Ottawa Scale

Summary

Miralax (PEG 3350) has been shown to be a safe and uncomplicated bowel preparation prior to colonoscopy in pediatric populations. This study seeks to confirm the efficacy of this bowel cleansing regimen in adults and to determine the benefit of adding a pretreatment medication to this bowel preparation. The tolerability of Miralax will hopefully improve patient satisfaction with colonoscopy and decrease their reluctance to be screened because of the uncomfortable taste and side effects of bowel preparation regimens.

Outcome Measures

OutcomeResultp-value
PRIMARY
The Cleanliness of the Prep as Measured by the Ottawa Scale
6.3; 6.8; 6.9; 5.1
SECONDARY
Patient Satisfaction With the Prep Measured by 5 Point Likert Scale
3.8; 4.1; 4.0; 3.2
SECONDARY
Procedure Time
21.3; 19.3; 20; 18.3
SECONDARY
Polyps Detected
128; 92; 90; 101

Eligibility Criteria

Inclusion Criteria

  • adult patients referred to our clinic for average or increased risk screening for colorectal cancer

Exclusion Criteria

  • elevated serum creatinine (Men >1.4mg/dL, Women >1.3mg/dL)
  • previous diagnosis of congestive heart failure
  • history of bowel obstruction
  • history of solid organ transplant
  • current pregnancy
  • lactating mother
  • participants allergic to either polyethylene glycol (Miralax), lubiprostone (Amitiza), or bisacodyl (Dulcolax)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00953017). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search